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ABSTRACT  Nerve  growth  factor  (NGF)  and  epidermal  growth  factor  (EGF) produce  stable 
alterations  in  PC12 cells  that persist  in the detergent-insoluble  cytoskeleton,  resulting in the 
phosphorylation  of a 250,000-mol-wt  cytoskeletally  associated  protein  in situ.  Treatment of 
PC12 cells  with  NGF or EGF, followed  by detergent lysis of the cells  and  incubation  of the 
resulting cytoskeletons with 3,-32p-ATP, permitted detection of hormonally stimulated, energy- 
dependent events, which result in the enhanced phosphorylation of a cytoskeletally associated 
protein  as an  immediate  consequence  of  receptor  occupancy.  These  events  were elicited 
only  upon  treatment  of  intact  cells  at  physiological  temperatures.  The  NGF-  and  EGF- 
stimulated events  occurred rapidly; however, they were a transient effect of hormone action. 
NGF and  EGF were found  to act through  independent  mechanisms  to stimulate the  in  situ 
phosphorylation  of the  250,000-mol-wt  protein,  as the  effects  of NGF,  but  not  EGF, were 
blocked by methyltransferase  inhibitors. The 250,000-mol-wt protein was phosphorylated on 
serine  and  threonine  residues  in  response  to  both  NGF  and  EGF  although  in  somewhat 
different  proportions. The data suggest that the hormone-stimulated  labeling of the 250,000- 
mol-wt  protein  may  be  the  result  of  either  the  direct  activation  of  a  protein  kinase,  the 
redistribution  of the kinase relative to its substrates  as a consequence of hormone action, or 
the coincident occurrence of these events. 
Although it is well known that the binding of peptide hor- 
mones to cell surface receptors results in various metabolic 
changes in the target cells, the mechanisms subserving these 
events are not well understood. Several hypotheses have been 
advanced to explain the myriad effects of peptide hormones, 
including the involvement of second messengers generated on 
hormone binding (1),  internalization of the  hormone and 
subsequent transport to the nucleus (2), and the activation of 
hormonally sensitive protein kinases (3). There is reasonably 
good evidence that  at  least  some of the biological effects, 
including the stimulation of DNA synthesis,  are the result of 
receptor aggregation within the plasma membrane (4-6). 
The role of protein kinases in hormone action is of partic- 
ular interest, given the recent discovery that the membrane 
receptors for several peptide hormones possess  an intrinsic 
protein kinase activity (7-12). The binding of hormone to its 
receptor immediately activates the protein kinase, resulting in 
autophosphorylation of the receptor itself as well as the phos- 
phorylation  of other  cellular proteins  (3,  7,  12-14).  It  is 
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presently uncertain what the significance  of these modifica- 
tions are, although it has been suggested that they are involved 
in  control  of cellular proliferation (15,  16). The  receptor 
kinases examined so far specifically  phosphorylate tyrosine 
residues,  a property hitherto believed to be limited to retro- 
viral gene products. Both classes of tyrosine kinases phospho- 
rylate cytoskeletal proteins (reference 17 and Landreth, G. E., 
G. D. Rieser, and L. K. Williams,  submitted for publication). 
A clonal rat pheochromocytoma, PC12, has proven to be a 
valuable model for neuronal differentiation. These cells re- 
spond to nerve growth factor (NGF)  ~  by cessation of division 
and development of a number of properties characteristic of 
mature  sympathetic neurons  (18).  These cells  possess  cell 
surface receptors for both NGF and epidermal growth factor 
(EGF).  The NGF  receptors display heterogeneous binding 
characteristics (19,  20),  with  one  class  of receptors being 
l Abbreviations  used in this paper.  EGF,  epidermal growth factor; 
NGF, nerve growth factor. 
677 associated with the cytoskeleton (20). 
Protein phosphorylation has been suggested to play a  role 
in NGF action in PCI 2 cells (l 8, 21-23). NGF stimulates the 
phosphorylation of a number of proteins and the dephospho- 
rylation of at least one protein (22).  Some of the effects of 
NGF  on  protein phosphorylation occur within the first  15 
min  of hormone  exposure,  whereas  others  require  longer 
periods, indicating that NGF modifies the activity of protein 
kinases or of phosphoprotein phosphatases both acutely and 
chronically (21 ). 
We  have approached the role of protein phosphorylation 
in hormone action in a somewhat different manner, by pos- 
tulating that hormone treatment of PC12 cells produces stable 
alterations in protein kinase activity or distribution  relative 
to its substrates. These experiments involve treating the cells 
with hormone and then lysing the cells with detergent under 
conditions where the cytoskeletal structure of the cell is pre- 
served and spatial relationships between proteins are retained 
(24, 25). Protein phosphorylation is then carried out in situ. 
The phosphoprotein labeling reflects the activity of immobi- 
lized protein kinases acting on protein substrates that are also 
associated with structural elements of the cell.  Using such a 
system,  we  have  detected  the  phosphorylation in  situ  of a 
250,000-mol-wt cytoskeletally associated protein in PC 12 cells 
following treatment of the cells with either NGF or EGF. 
MATERIALS  AND  METHODS 
Materials:  Dulbecco's modified Eagle's medium and fetal calf serum 
were from Gibco Laboratories (Grand Island, NY) and horse serum from KC 
Biological, Inc. (Lenexa, KS). EGF was purchased from Collaborative Research 
Inc. (Lexington, MA). NGF was prepared by the method of Burton et al. (26). 
Radiolabeled ATP was purchased from ICN Pharmaceuticals, Inc. (Irvine, CA) 
or synthesized  using GammaPrep  A  from  Promega-Biotech Inc.  (Madison, 
WI); [32p]orthophosphate was also from ICN Pharmaceuticals, Inc. Phospho- 
tyrosine standard was generously provided by Dr. M. A. Bothwell (Princeton 
University,  NJ).  Cellulose thin  layer chromatography plates  (MN300)  were 
from Brinkmann Instruments,  lnc. (Westbury,  NY).  Triton X-100 was from 
Sigma Chemical Co. (St.  Louis, MO). 
Cell Culture:  PCI2 cells were grown in Dulbecco's modified Eagle's 
medium containing 5% fetal calf  serum and 10% horse serum in an atmosphere 
of 88% air,  12% CO2. 
In  Situ  Phosphorylation:  PCI2  cells were  harvested  from tissue 
culture dishes  with calcium- and  magnesium-free PBS containing  l  mg/ml 
BSA  and  (except where indicated)  l  mg/ml glucose. The cells were washed 
twice and resuspended at a concentration of l06 cells/mL NGF and EGF were 
added to aliquots of the cell suspension and incubated at 37"C.  The cells were 
pelleted by centrifugation, gently resuspended in 0.15% Triton X-100, 25 mM 
HEPES, pH 7.4, 2 mM  MnCl2, and  1 mM phcnylmethylsulfonyl fluoride (0.5 
ml/106 cells), and incubated for 2 min at 4"C. The resulting cytoskeletons were 
centrifuged for 1 rain in a Beckman Microfuge B (Beckman Instruments, Inc., 
Palo Alto, CA) and resuspended in cold detergent-free buffer (0. l ml/106 cells), 
and 3,-~2p-ATP was added (10 uM,  55 dpm/fmol ATP). The phosphorylation 
reaction  was carried out for  l0  rain at 4"C and  stopped  by the addition  of 
electrophoresis sample buffer and heating to 100*C for 5 min. 
SDS PAGE:  The cytoskeletal  proteins were separated on 4-13%  or 5- 
15% polyacrylamide gradient gels as described by Laemmli (27).  The proteins 
were stained with 0. 1% Coomassie Blue and the gels were dried and exposed 
to Kodak XAR film with or without Lighting Plus intensifying  screens (E.  I. 
DuPont de Nemours &  Co.,  Newtown,  CT).  Autoradiograms were scanned 
densitometrically  using a Beckman DU8 spectrophotometer. 
Phosphoamino Acid Analysis:  The  32P-labeled  250,000-mol-wt 
protein was excised  from the dried gel, rehydrated in 50 mM  NH4HCO3,  pH 
8.0,  0.05% SDS containing 50 #g/ml Proteinase K, and incubated overnight  at 
room temperature.  The  solubilized protein was  collected,  lyophilized, and 
hydrolyzed  for  2  h  at  l l0*C  in  6  N  HCI.  The  labeled amino  acids were 
combined with a mixture of phosphoamino acid standards and an aliquot was 
applied to cellulose thin layer plates. The phosphoamino acids were separated 
in the first dimension by electrophoresis at pH  1.9 for 1 h (l kV), followed by 
ascending chromatography  in isohutyric  acid/0.5 M NH4OH (5:3)in the second 
dimension. The chromatogram was then exposed  to Kodak XAR film. 
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RESULTS 
Treatment of PC 12 cells with NGF or EGF resulted in stable 
changes within the cells, which persisted upon detergent lysis 
and resulted in enhanced phosphorylation of a 250,000-mol- 
wt cytoskeletally associated protein in situ (Fig.  1). The term 
"cytoskeleton" is operationally defined as those elements of 
the cell that are insoluble in non-ionic detergent and include, 
in addition to fbrous structural proteins, the nucleus, surface 
lamina,  and  associated  proteins.  The  phosphorylation was 
due to the action of a protein kinase which was also cytoskel- 
etally  associated  and  in  proximity  to  the  250,000-mol-wt 
substrate. The phosphorylation reaction occurs under condi- 
tions  that  preserve  cytoskeletal  structure  (except  microtu- 
bules). Indeed, identical results were obtained using the more 
stringent buffer conditions of Burr et at.  (24)  and  also with 
the buffer of Schliwa and van Blerkom (25)  which was re- 
ported to preserve cellular microtubules. Neither the 250,000- 
mol-wt protein nor any protein kinase was found in solution 
in cytoskeletal preparations of PC 12  cells, as determined by 
direct assay of the buffer for protein kinase activity and for 
labeled 250,000-mol-wt protein released from the cytoskeletal 
preparation during the phosphorylation reaction.  Extensive 
washing of the cytoskeletons in detergent-free buffer had no 
effect on the in situ phosphorylation of the 250,000-mol-wt 
cytoskeletal protein. 
The 250,000-mol-wt protein was observed to be present in 
small  amounts  in  the  PC12  cell  cytoskeleton but  became 
highly phosphorylated in situ upon hormone treatment of the 
cells.  The  250,000-mol-wt  protein  appears  to  be  the  only 
protein whose phosphorylation was dramatically enhanced by 
hormone treatment; still,  we cannot rule out the presence of 
other lower  molecular weight  proteins  whose  labeling  was 
stimulated less markedly. Similar results were obtained using 
3,-32p-ATP and 3,-3sS-thiol-ATP.  The phosphorylation of the 
250,000-mol-wt protein occurred using either Mn  ÷+ or Mg  ÷+. 
The magnitude of the hormone-stimulated phosphorylation 
of the  250,000-mol-wt  protein  varied between experiments 
from two- to fivefold greater than controls. 
FIGURE  1  NGF- and EGF- 
stimulated  phosphoryla- 
tion  of  cytoskeletal  pro- 
tein.  PC12  cells  were  in- 
cubated in the presence or 
absence  of  10  ng/ml  of 
either  NGF  or  EGF  for  5 
min  at  37°C.  Cytoskele- 
tons  were  prepared  and 
then  incubated  with  [32p] 
ATP for 10 min at 4°C. The 
cytoskeletal proteins were 
separated  on  4-13%  SDS 
polyacrylamide gels.  Coo- 
massie  Blue-stained  cyto- 
skeletal proteins are shown 
in  lane  a.  Autoradiograms 
of  32p-labeled  phospho- 
proteins  from  untreated 
cells  (lane  b);  and  cells 
treated with  NGF (lane c), 
EGF (lane d), or both NGF 
and  EGF  (lane e).  The  po- 
sitions of molecular weight 
markers  (Xl0  -3)  are 
shown. NGF and EGF stimulated the in situ phosphorylation of 
the 250,000-mol-wt protein by independent mechanisms. The 
effects of NGF on PC12 cells can be blocked by methyltrans- 
ferase inhibitors whereas those of EGF are unaffected (28). 
PC I 2 cells were preincubated with 3 mM 5'-S-methyl aden- 
osine for 30 min before the addition of either NGF or EGF. 
The methyltransferase inhibitor blocked the NGF-stimulated 
in  situ  phosphorylation of the  250,000-mol-wt protein  but 
had no effect on the phosphorylation produced by EGF (Fig. 
2). These data indicate that the two hormones act through 
mechanistically distinct pathways to produce the in situ phos- 
phorylation of the 250,000-mol-wt cytoskeletally associated 
protein. This conclusion is supported by two additional lines 
of evidence. First,  the addition of NGF and EGF (with each 
at  concentrations  that  maximally  stimulate  the  response) 
together produced  phosphorylation of the  250,000-mol-wt 
protein at a level greater than that produced by the individual 
hormones alone (Table I and Fig.  1). Although the effects of 
the hormones were not additive, these observations suggest 
that  the  two  hormones  act  independently  to  produce  the 
response. Second, acid hydrolysis of the 250,000-mol-wt pro- 
tein  and  separation of the  labeled phosphoamino acids re- 
vealed only 3ZP-labeled phosphoserine and phosphothreonine 
residues.  NGF  and  EGF  stimulated  the  labeling  of both 
residues although in different proportions, indicating that the 
two  hormones  produce  protein  phosphorylation,  but  with 
different specificities  (Fig.  3).  In addition,  the data demon- 
strate that, at least for EGF, the protein phosphorylation was 
not the result of the EGF-receptor kinase activity, since this 
enzyme specifically phosphorylates tyrosine residues (10). 
The ability of both NGF and EGF to stimulate the phos- 
phorylation of  the 250,000-mol-wt protein required treatment 
of intact cells (Fig.  4). In vitro exposure of cytoskeletons to 
hormone has no effect on protein phosphorylation, indicating 
either that  the  relevant enzymes were not  activated under 
these circumstances, that the substrates were not positioned 
near the kinases, or that the hormone receptors were lost on 
detergent lysis. It was also possible that the changes resulting 
in the in situ phosphorylation required an integrated cellular 
response, some aspect of which was lost on detergent treat- 
ment. 
FtoueE  2  Effect  of  methyltransferase 
inhibitors on the phosphorylation of the 
250,000-mol-wt  cytoskeleta[  protein. 
PC12  cells  were  incubated  in  the  ab- 
sence (lane a) or presence ([anes b-d) of 
3 mM 5'-S-methyl adenosine for 30 rain 
at  37°C;  NGF  (lanes  a  and  c)  or  EGF 
(lane d) was then added (50 ng/ml) and 
the incubation was carried out for 5 min 
more.  Cytoskeletons  prepared  from 
these  cells  were  then  incubated  with 
[32P]ATP  for  10  min  at  4°C.  Autoradi- 
ograms of the 3ZP-labeled  phosphopro- 
teins  are  shown;  the  position  of  the 
250,000-mol-wt protein is indicated. 
TABLE  I 
Effect of NCF and EGF A/one or Combined on the 
Phosphorylation of the 250,000 mol-wt Protein 
Radioactivity incorporated 
Untreated  1.00 
NGF  1.82 {0.10) 
EGF  1.69 (0.23) 
NGF +  EGF  2.18 (0.61) 
PC12 ceils were incubated with 10 nglm[ NGF, EGF, or both hormones for 5 
min at 37"C. Cytoskeletons were prepared and incubated for 10 rain at 4"C 
with ~2P-ATP. The cytoskeletal proteins were separated on 4-13% polyacryl- 
amide gels and autoradiograms were prepared. The autoradio~,rams  were 
scanned densitometrically  and radioactivity  in the 250,000-mol-wt  protein 
was determined. The radioactivity present in the 250,000-mol-wt  band as a 
percentage of total cytoskeletally incorporated radioactivity was determined, 
with data from hormonalIy stimulated samples  expressed  relative to untreated 
cells. The data are the mean (--. SD) of five separate experiments. 
A  B 
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F~unE  3  Phosphoamino acid analysis of the 250,000-mol-wt cy- 
toskeletal protein. The 250,000-mol-wt  PC12  cytoskeletal protein 
from cells treated for 5 min at 37°C with  10 ng]ml NGF (A) or EGF 
(B) was subjected to acid hydrolysis, and the phosphoamino acids 
were separated by electrophoresis at pH  1.9  (vertical dimension) 
followed by ascending chromatography in isobutyric acid/NH4OH 
(horizontal dimension). The positions of phosphoamino acid stand- 
ards are indicated. These data are representative of three separate 
experiments. 
At low temperature (4°C), the ability of NGF and EGF to 
stimulate  250,000-mol-wt  protein  phosphorylation was  ar- 
rested  (Fig.  4).  This was not due to  any lack of hormone 
binding, since both NGF (20) and EGF (29) binding occurs 
at low temperature, although at diminished levels. The exper- 
iments were performed using hormone concentrations (50 
ng/ml)  sufficient  to  result  in  receptor occupancy at  levels 
known to maximally stimulate the response. 
When PC 12 cells were incubated in the presence of  glucose, 
the  in  situ  phosphorylation of the  250,000-mol-wt protein 
was measurably enhanced compared with cells in glucose-free 
medium (Fig. 5); however, if PC I2 cells were pretreated with 
10 mM sodium azide, the phosphorylation of the 250,000- 
mol-wt protein was blocked. Azide treatment resulted in  a 
70%  reduction in intracellular ATP content compared with 
cells incubated in glucose-containing medium (5.5 and  18.2 
fmol ATP/celI, respectively),  which indicates that the events 
required for 250,000-mol-wt protein phosphorylation require 
metabolic energy. In the azide-treated cells, the in situ labeling 
of other cytoskeletal phosphoproteins was uniformly greater 
than in untreated cells. This latter effect is likely to be due to 
back-phosphorylation as a result of lower ATP levels in vivo, 
which  would  diminish  protein  phosphorylation  but  leave 
cellular  phosphatase activities unimpaired,  thus  generating 
unoccupied phosphorylation sites that are subsequently phos- 
phorylated in situ. 
Two important conclusions can be drawn from this exper- 
iment:  (a)  inclusion  of glucose in  the  incubation  medium 
enhances in situ phosphorylation of the 250,000-mol-wt pro- 
tein; and (b) azide blocks this event. These data demonstrate 
that metabolic energy is required to elicit  the cellular events 
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with half-maximal stimulation occurring below  1 ng/ml for 
both NGF and EGF (38 and  165 pM, respectively).  This is 
similar to the concentration dependence of other effects  of 
the hormones on these cells, indicating that maximal effects 
occur at low levels of receptor occupancy. 
There was a dramatic difference in the in situ labeling of 
the 250,000-mol-wt protein with different periods of  hormone 
exposure of the  PCI2  cells  (Fig.  8).  Both  EGF and  NGF 
maximally  stimulated  the  in  situ  phosphorylation  of  the 
250,000-mol-wt protein within 5 min of hormone exposure. 
The amount of radioactivity incorporated into the 250,000- 
mol-wt protein in situ decreased with longer exposure of the 
cells to NGF. These data demonstrated that the initial hor- 
mone-stimulated  phosphorylation  occurred  with  a  time 
course that  closely  paralleled the  association  of hormones 
with their cell surface receptors (l 9, 30), which indicates that 
the hormone-mediated changes resulting in the phosphoryla- 
FIGURE  4  In situ phosphorylation of the 250,000-mol-wt cytoskel- 
etal protein requires hormone treatment of intact cells at physio- 
logical  temperatures.  Cytoskeletons  were  prepared  from  naive 
PC12 cells (lanes a-f) and then received either no additions (lanes 
a and d) or 50 nglml of NGF (lanes b and e) or EGF (lanes c and f); 
they were incubated for 5 min at 37°C (lanes a-c) or 4°C (lanes d- 
f) and then again for 10 min more at 4°C with [32P]ATP. Intact PC12 
cells were incubated alone (lanes g and j) or with 50 ng/ml of either 
NGF (lanes h and k) or EGF (lanes i and I) at 4°C (lanes g-i) or 37°C 
(lanes j-I)  for 5  min; cytoskeletons were then  prepared and incu- 
bated for  10 min with [32P]ATP. An  autoradiogram of the  labeled 
cytoskeletal  phosphoproteins  is  shown.  The  Coomassie  Blue- 
stained cytoskeletal proteins are shown (m), and the  positions of 
molecular weight markers (x 10  -3) are indicated. 
leading to the phosphorylafion of the 250,000-mol-wt protein 
in situ, 
A concern in these experiments was that the hormone may 
have stimulated in vivo phosphorylation or dephosphoryla- 
tion of the 250,000-mol-wt protein, influencing the level of 
32p labeling observed subsequently to be incorporated in situ, 
due to altered levels of occupancy of phosphorylation sites 
with phosphate from endogenous ATP pools. To test directly 
if hormone treatment modified the in vivo phosphorylation 
of the 250,O00-mol-wt protein, we preincubated the cells with 
[32p]orthophosphate  and  followed this by addition  of hor- 
mone and incubation at 37"C. NGF treatment of PC12 cells 
resulted in a small stimulation of  labeling of  the 250,000-mol- 
wt cytoskeletal protein (Fig.  6).  This result was variable in 
magnitude and inconsistently obtained. The significance  of 
this observation was that in no case was there a diminution 
of labeling of  the 250,000-mol-wt protein in vivo, demonstrat- 
ing that the 250,000-mol-wt protein was not specifically  de- 
phosphorylated  as  a  consequence  of  hormone  treatment. 
These data argue that the enhanced in situ phosphorylation 
was not a consequence of phosphoprotein phosphatase activ- 
ity in vivo, resulting in the dephosphorylation of the 250,000- 
mol-wt protein, which would generate unoccupied phospho- 
rylation sites  that could subsequently be phosphorylated in 
situ. 
The effect of NGF and EGF on the in situ phosphorylation 
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Fioure  5  Effect  of  glucose  and 
azide on the in situ phosphorylation 
of  the  250,000-mol-wt  cytoskeletal 
protein.  PC12  cells were  incubated 
alone  (lane  a)  or  with  20  ngJml  of 
NGF  (lanes  b-d)  in  PBS (lanes  a, b, 
and d), or supplemented with I  mgJ 
ml  glucose  (lane  c).  One  group  of 
cells (lane d) was preincubated with 
10 mM sodium azide for 30 rain be- 
fore hormone addition. After a 5-rain 
incubation at 37°C  with  NGF, cyto- 
skeletons were  prepared  and  incu- 
bated  with  [32P]ATP for  10  rain  at 
4°C.  An  autoradiogram  of  the  la- 
beled phosphoproteins is shown. 
FIGURE  6  In vivo labeling of PC12 cytoskel- 
etal proteins. PC12 cells were incubated with 
50 #Ci]ml [32P]orthophosphate in phosphate- 
free growth medium for 3 h at 37°C. The cells 
were then incubated in the absence (lane A) 
or presence {lane B) of 20 nglml NGF for 10 
rain. The cells were lysed and the cytoskeletal 
proteins were separated on  4-13%  polyac- 
rylamide  gels.  An  autoradiogram of  the  la- 
beled phosphoproteins is shown.  The  posi- 
tion of the 250,000-mol-wt protein (arrow)  is 
shown. tion of the 250,000-mol-wt protein were an immediate con- 
sequence of receptor occupancy. This is one of the most rapid 
biochemical effects of either hormone yet demonstrated on 
these cells.  The subsequent fall in 32p incorporated into the 
250,000-mol-wt protein indicated that the events leading to 
the in situ phosphorylation were a transient consequence of 
hormone action. 
The NGF- and EGF-mediated events resulting in the phos- 
phorylation of the  250,000-mol-wt protein, once they have 
occurred, were themselves stable in the cytoskeletal prepara- 
tions (Fig. 9). PC12 cells were incubated with EGF for 10 min 
at 37"C and the cytoskeletons were prepared and incubated 
with  radiolabeled  ATP  for  1-20  min.  There  was  a  time- 
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FIGURE  7  Concentration  dependence  of  hormone-stimulated 
phosphorylation of the 250,000-mol-wt cytoskeletal protein. PC12 
cells  were incubated with the  indicated concentration of either 
NGF (O) or EGF (O) for 15 min at 37°C. Cytoskeletons  were then 
prepared and  incubated with  [32P]ATP for  10  min  at  4°C.  The 
resulting  autoradiograms were densitometrically scanned  and the 
radioactivity in the 250,000-mol-wt protein was determined. 
dependent  increase  in  the  labeling  of the  250,000-mol-wt 
protein similar to that observed with other cytoskeletal phos- 
phoproteins. Identical results were obtained with NGF. These 
data indicate that the transient nature of the cellular response 
is not a consequence of the lability of the hormone-produced 
events leading to the phosphorylation of the 250,000-mol-wt 
protein in situ. 
Several agents were also tested for their effect on the phos- 
phorylation of the 250,000-mol-wt cytoskeletal protein. PC 12 
cells or cytoskeletons were incubated, without effect,  with  I 
mM Ca  ++, 0.01-1  mM cyclic AMP (or 1 mM dibutryl cyclic 
AMP for whole cells), 20-50 #M cytochalasin D,  10-80 ttM 
trifluorperazine, and 10 mM dansylcadaverine. 
The identity of the 250,000-mol-wt cytoskeletal protein is 
unknown.  Two obvious candidates are fodrin and  filamin. 
We have been unable to immunoprecipitate the phosphoryl- 
ated  250,000-mol-wt  protein  with  antisera to  fodrin  or  to 
chicken gizzard filamin (Amersham Corp., Arlington Heights, 
IL) by using the method of Levine and Willard (31). 
DISCUSSION 
We have shown that hormone treatment of PC 12 cells resulted 
in  stable cellular changes that persisted in the  cytoskeleton 
following extraction of the cells  in  non-ionic detergent and 
led to the phosphorylation of a 250,000-mol-wt cytoskeletally 
associated protein in  situ.  The experiments were performed 
on cytoskeletons prepared from hormonally treated cells un- 
der conditions where cytoskeletal structure (except microtu- 
bules) is preserved; thus, the protein phosphorylation occurred 
between immobilized enzyme and substrate (25).  These ex- 
periments have demonstrated that  NGF and  EGF rapidly, 
but  transiently,  produced  cellular  events as  an  immediate 
consequence of receptor occupancy, resulting in the enhanced 
phosphorylation of a single cytoskeletally associated protein. 
This type of hormonally mediated change has not previously 
been observed, and it provides a  new measure of hormone 
FIGURe:  8  Time course of hormone treatment of PC12 cells on the in situ phosphorylation of the 250,000-mol-wt cytoskeletal 
protein. (A) PC12 cells were incubated with 10 ng/ml EGF for the indicated periods and then cytoskeletons were prepared and 
incubated with [32P]ATP for 10 min at 4°C. Autoradiograms of the labeled phosphoproteins were scanned densitometricaFly and 
the radioactivity in the 250,000-mol-wt cytoskeletal protein was determined. The amounts of 32p incorporated into the 250,000- 
mol-wt protein in untreated controls and from cells treated with EGF for 5 min were 1.0 and 4.9%,  respectively: The data are 
representative of three separate experiments. (B) Autoradiogram of cytoskeletal phosphoproteins from PC12 cells treated with 
10 ng/ml NGF for the indicated time periods. The cytoskeletal proteins were phosphorylated by a 10-min incubation with 3ss- 
thiol-ATP.  The data are representative of seven separate experiments. 
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the 250,000-mol-wt protein. PC12 cells were treated with NGF (10 
ng/ml)  for 5 min at 37"C, and then cytoskeletons  were prepared 
and incubated with [32P]ATP  for 1 (lane a), 5 (lane b),  10 (lane c), 
or 20 min (lane d). An autoradiogram of the labeled phosphopro- 
teins is shown. 
action, permitting the investigation of the primary events in 
the mechanism of NGF and EGF action. 
The hormonally enhanced protein labeling in situ can arise 
from either (a) direct activation of a cytoskeletally associated 
protein kinase,  (b) hormonally induced cytoskeletal attach- 
ment of either the protein kinase or its substrates, (c) redistri- 
bution of the enzyme in proximity to its substrates, or (d) the 
coincident occurrence of any of these events. 
The  hormonally  stimulated  phosphorylation  of  the 
250,000-mol-wt protein  may be the  result  of direct  kinase 
activation. As we have no direct evidence for this, experiments 
are currently in progress to test this possibility. Halegoua and 
Patrick (2 l) reported that both NGF and EGF independently 
stimulated the phosphorylation of a number of different cel- 
lular proteins in PC I2 cells. 
The  hormonally  stimulated  phosphorylation  of  the 
250,000-mol-wt  cytoskeletal  protein  may  be  the  result  of 
active redistribution of either the enzyme or its substrate by 
an energy-requiring process. Two types of reorganization may 
be involved. Hormone treatment of PC 12 cells may result in 
the transfer of the enzyme or its substrate from the cytoplasm 
to cytoskeletal elements or,  alternatively, may promote the 
attachment of membrane proteins to  structural  proteins of 
the  "surface lamina" (32).  There is  evidence that the  latter 
type of interaction occurs with the NGF receptors on these 
cells (20). 
The second possibility is that hormone treatment promotes 
a redistribution of membrane proteins, which occur as a result 
of the rapid and dramatic changes in cell surface morphology. 
Both NGF and EGF produce an immediate increase in mem- 
brane  ruffling  which  persists  for  ~10  min  after  hormone 
exposure and the loss of microvilli in  PC12  cells  within  15 
min (33, 34). Similar events occur on EGF treatment of A431 
cells  (35).  Interestingly,  Rous  sarcoma  virus-infected  cells, 
which  possess a  membrane-associated tyrosine  kinase,  also 
undergo an analogous change in cell surface architecture (36, 
37). These cell surface changes are accompanied by alterations 
in spatial relationships between proteins, and it is not unrea- 
sonable that during this process active protein kinases may 
become associated with their substrates, perhaps transiently. 
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PC12 cells also undergo a separate class of events involving 
the distribution  of cell surface proteins which accompanies 
cellular  processing  of the  hormone.  Following  binding  of 
hormone to cell  surface receptors, the  receptors translocate 
within the membrane and aggregate prior to their internali- 
zation (38).  The aggregation of receptors is arrested at 0*C, 
while the  internalization  of the  hormone-receptor complex 
requires metabolic energy. 
The nature of the cellular events subserving the hormone- 
stimulated phosphorylation of the 250,000-mol-wt protein is 
unclear. Those changes, however, are dependent on metabolic 
energy as demonstrated by the inability of NGF to elicit the 
phosphorylation of the 250,000-mol-wt protein in cells whose 
ATP pools were depleted by 70%. 
We  believe that  it  is  unlikely  that  the  enhanced  in  situ 
phosphorylation  of the  250,000-mol-wt  protein  is  due  to 
active dephosphorylation of  the protein in vivo by hormonally 
stimulated  phosphoprotein  phosphatases.  In  PC I2  cells  la- 
beled  with  32P-orthophosphate  we  have  been  consistently 
unable to detect the dephosphorylation of the 250,000-mol- 
wt protein in vivo. These data indicate that hormone-stimu- 
lated phosphatase activation is not likely to occur. The vari- 
able extent of in vivo labeling of the 250,000-mol-wt protein 
suggests that its phosphorylation state in vivo may be tightly 
regulated, and that we are able to detect it in situ because of 
the  removal  of active  phosphoprotein  phosphatases  upon 
detergent treatment of the cells. This suggestion is supported 
by the recent observation that phosphotyrosyl phosphatases 
are  approximately one  hundred-fold  more active than  the 
respective kinases (39). 
The cellular mechanisms subserving the actions of NGF 
and EGF appear to be distinct.  A broad spectrum of NGF- 
mediated events is blocked by inhibition of methyltransferase 
reactions; however, those elicited by EGF are unaffected or 
enhanced (28).  These data suggest that methylation is a very 
early and obligatory step in the mechanism of action of NGF. 
The  inhibition  of NGF-stimulated  phosphorylation  of the 
250,000-mol-wt protein provides additional evidence that the 
two hormones operate through independent mechanisms to 
elicit their biological effects. Furthermore, the ability of NGF 
and EGF, when added simultaneously, to stimulate the phos- 
phorylation of the  250,000-mol-wt protein  at levels greater 
than those produced by the individual hormones alone, and 
the different ratios of serine and threonine phosphorylation 
produced by the two hormones, support this hypothesis. The 
combined effect of NGF and EGF, however, is not additive. 
This  result  may  be  due  to  low  substrate  concentration,  a 
possibility difficult to assess  given the  small amount of the 
250,000-mol-wt protein present in the cytoskeleton and the 
immobilization of both enzyme and substrate. 
It is of some interest that Connolly et al. (34) have recently 
reported that NGF and EGF treatment of PC 12 cells resulted 
in a  large increase in coated pit density on the cell  surface. 
This effect occurred  maximally within  3  min  of hormone 
treatment. If  both hormones were added, the combined treat- 
ment resulted in a quantity of coated pits only slightly greater 
than that produced by the individual hormones. 
PC12 cells respond to NGF and EGF by phosphorylating 
a  number of cellular proteins (21).  The phosphorylation of 
several of these proteins was common to both NGF and EGF, 
but NGF uniquely stimulated labeling of a few other specific 
proteins. Similarly, both hormones stimulated the phospho- 
rylation ofa 30,000-mol-wt nuclear protein in these cells (23). These observations are of interest in that EGF and NGF share 
a  set  of positive  pleiotypic  actions  on  these  cells  and  are 
processed by the cell in a generally similar manner (29,  30). 
NGF,  however,  inhibits  cell  proliferation  and  directs  the 
acquisition  of a  neuronal phenotype  by these cells.  Not un- 
expectedly, there are specific changes in cellular phosphopro- 
teins associated  with differentiating  events as demonstrated 
by the increased abundance  of the 32p-labeled  microtubule- 
associated protein MAP- 1 (18). 
The results here clarify several aspects of hormone action 
on  PC I2 cells.  It is clear that both NGF and  EGF produce 
stable alterations in these cells which can be detected using a 
cell-free  system.  The  molecular  events  responsible  for  the 
enhanced labeling of cytoskeletal proteins in situ are initiated 
immediately on binding of hormone to its receptor and are a 
transient  consequence  of  hormone  action.  Whether  these 
changes are directly involved in the generation of the cellular 
responses to the hormones, or are linked to processing of the 
hormone by common mechanisms, is presently under inves- 
tigation. 
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